sacituzumab
gilead sciences
['tropics-02', 'trodelvy', 'gilead']
 presented the results from the phase iii tropics-02 clinical trial evaluating trodelvy at the ongoing 2022 conference. get a more detailed assessment at: #esmo2022 #esmo #esmo22 
#DelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the healthcare industry